An observational study in Glucose Fluctuations in Sepsis, sponsored by Assiut University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-11-19.
Sponsored by Assiut University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 33 studies in Sepsis by Assiut University — 23 open to participants now, 23 under way, 1 of them phase 3. Sepsis · Assiut University.
Among the 33 studies in Sepsis by Assiut University, this one is the 10th largest by planned enrollment of the 29 observational ones that give a count, is one of 13 that started in 2026, is one of 29 observational ones, reaches primary completion later than 21 of the 22 other live ones, and was the 19th registered.
2,425 studies on the registry are indexed under Sepsis; 543 are open to participants now.
Browse Sepsis studies →23 of the 33 studies in Sepsis by Assiut University are open now, in 1 country. Recruiting first, the newest first:
Assiut University · Sites in Egypt
Ages 18–65
Assiut University
Ages 18–65
Assiut University
Ages 18+
Assiut University
Ages 18+
Assiut University
Ages 18+
By country, each count listing its studies:
Of the 319 Sepsis studies recruiting now, 212 (66%) set no upper age limit and 52 (16%) stop at 75 or younger; 67 take children under 18; 43 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
33 studies; the count open now beside each. This study's row is marked.
First in 2016; this study’s year is marked. 13 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 105 is below the median of 150 across 1,166 observational studies indexed under Sepsis.
Median enrollment 85 across the 4 interventional studies, 100 across the 29 observational. Of the 1 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Assiut University is the lead sponsor of 5,094 studies on the registry; 2,187 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
11 of the studies in Sepsis by Assiut University that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04910464Phase 3Assiut UniversityEarly Tranexamic Acid and Modulating the Inflammatory Response in Sepsis | 2027-01-10 |
| NCT07832903Assiut UniversitySerial Platelet Count and Indices for Predicting In-Hospital Mortality in Sepsis | 2026-11 |
| NCT07030114Assiut UniversityThe Study Seeks to Determine Potential Correlations Between Ventilation and Hematological Alterations, Contributing to a Better Understanding of Its Physiological Effects and Optimizing Patient Management in Critical Care Settings. | 2027-04 |
| NCT07663084Assiut UniversityCBC Indices and Serum Lactate in Neonatal Sepsis | 2027-08 |
| NCT07739251Assiut UniversityRelation of Serum Phosphate Level to the Duration of Mechanical Ventilation in Patient With Sepsis | 2027-09 |
Add all 11 to your calendar (.ics) → With an account.
Among the 33 studies in Sepsis by Assiut University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
To determine whether glucose fluctuations prior to antibiotic administration are associated with sepsis severity and poor clinical outcomes.
Sepsis is a life-threatening condition caused by the body's overwhelming response to infection. It is a major cause of death in intensive care units (ICUs) despite advances in treatment. One of the body's common responses to sepsis is a disturbance in blood sugar levels, even in patients without diabetes. These changes, known as glycemic variability, include both high and low glucose levels and rapid swings between them.
Recent studies suggest that glycemic variability the early hours of sepsis may be linked to worse outcomes, including organ failure and death .Unlike average glucose levels, these fluctuations can reflect how stressed the body is.
A newer marker called the Glycemic Shock Index (GSI) - calculated by dividing blood glucose by mean arterial pressure (MAP)- may help capture both metabolic and circulatory stress.
Another factor of interest is the time it takes for blood sugar to return to normal after starting antibiotics.
Early normalization may signal a better response to treatment, while persistent abnormal levels could predict complications.
Understanding how early glucose changes relate to sepsis severity may help us identify high-risk patients sooner. This study focuses on glucose fluctuations before antibiotics, time to glucose normalization, and GSI, and how they relate to outcomes like mortality, organ failure like AKI and ICU stay.
Critical care unit of assiut university hospital.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
ICU mortality
ICU mortality due to septic shock and associated glucose level fluctuations pre and post antibiotic administration
Time frame: Baseline
AKI
number of patients suffering from AKI due to septic shock
Time frame: Baseline
Need for vasopressor support within first 24 hours.
Number of patients who needed norepinephrine or other vasopressors during first day of ICU admission
Time frame: First 24 hours of ICU admission
Length of ICU stay
Length of ICU stay until improvement or death
Time frame: Start from patient admission to ICU unti patient discharge or death for any cause (whichever comes first) up to 1 year
No study locations are listed for this record.
Plan to share: Undecided — Patients may not agree
No publications or documents are linked to this record.
Start is estimated for Dec 2026; primary completion for Dec 2028, 24 months later.
Of 496 non-industry observational studies under Sepsis, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 57. This study's planned 24 months is below that.
Counting every sponsor, half of 548 studies reached it within 27 months; a quarter within 12 and three quarters within 55.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.